Zobrazeno 1 - 10
of 201
pro vyhledávání: '"Topiramate YL Study Group"'
Autor:
Glauser TA; Children's Comprehensive Epilepsy Program, Children's Hospital Medical Center, Cincinnati, Ohio 45229, USA., Levisohn PM, Ritter F, Sachdeo RC
Publikováno v:
Epilepsia [Epilepsia] 2000; Vol. 41 (S1), pp. 86-90.
Autor:
Sachdeo RC; Department of Neurology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08903-0019, USA., Glauser TA, Ritter F, Reife R, Lim P, Pledger G
Publikováno v:
Neurology [Neurology] 1999 Jun 10; Vol. 52 (9), pp. 1882-7.
Publikováno v:
Epilepsia. 41(S1)
The response to topiramate (TPM) as long-term adjunctive therapy was evaluated in patients with Lennox-Gastaut syndrome (LGS) in a long-term, open-label extension to a double-blind, placebo-controlled trial.In 97 patients with LGS (mean age, 11 years
A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group
Publikováno v:
Neurology. 52(9)
To evaluate the efficacy and safety of topiramate as adjunctive therapy for Lennox-Gastaut syndrome in a multicenter, double-blind, placebo-controlled trial.Conventional antiepileptic drugs are frequently ineffective against multiple-seizure types of
Autor:
Buraniqi E; Division of Child and Adolescent Neurology, Department of Neurology, Mayo Clinic, 200 First St., SW, Rochester, MN, 55905, USA., Dabaja H; Division of Child and Adolescent Neurology, Department of Neurology, Mayo Clinic, 200 First St., SW, Rochester, MN, 55905, USA., Wirrell EC; Division of Child and Adolescent Neurology, Department of Neurology, Mayo Clinic, 200 First St., SW, Rochester, MN, 55905, USA. Wirrell.Elaine@mayo.edu.
Publikováno v:
Paediatric drugs [Paediatr Drugs] 2022 Jul; Vol. 24 (4), pp. 335-363. Date of Electronic Publication: 2022 May 21.
Autor:
Auvin S; INSERM NeuroDiderot, Université Paris Cité, Paris, France.; Pediatric Neurology Department, CRMR Epilepsies Rares, ERN EpiCare, APHP, Robert Debré University Hospital, Paris, France.; Institut Universitaire de France, (IUF), Paris, France., Arzimanoglou A; Epilepsy Unit, Child Neurology Department, Hospital San Juan de Déu, Coordinator of the ERN EpiCARE, Universitat de Barcelona, Barcelona, Spain., Falip M; Epilepsy Unit, Neurology Service, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain., Striano P; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.; IRCCS 'G. Gaslini' Institute, ERN EpiCARE, Genoa, Italy., Cross JH; UCL NIHR BRC Great Ormond Street Institute of Child Health, London, UK.
Publikováno v:
Epilepsia open [Epilepsia Open] 2024 Dec 19. Date of Electronic Publication: 2024 Dec 19.
Publikováno v:
Expert Opinion on Pharmacotherapy; Aug2023, Vol. 24 Issue 11, p1249-1268, 20p
Publikováno v:
Epilepsia (Series 4); Jul2023, Vol. 64 Issue 7, p1812-1820, 9p
Autor:
GÖL, Mehmet Fatih1 m-fatih-gol@hotmail.com, ERDOĞAN, Füsun Ferda1
Publikováno v:
Epilepsi: Journal of the Turkish Epilepsi Society. 2018, Vol. 24 Issue 2, p83-86. 4p.
Publikováno v:
CNS Drugs; Oct2022, Vol. 36 Issue 10, p1079-1111, 33p